Acute lymphocytic myocarditis characterized by cardiogenic shock and conduction system abnormalities in patients with Hashimoto’s thyroiditis: a case report and review of literature
Germana Panattoni, Marco Marino, Andrea Ascione, Giulia d’Amati, Leonardo Calò

TL;DR
A patient with Hashimoto’s thyroiditis developed severe heart inflammation and conduction issues, which improved with treatment including corticosteroids and vasopressors.
Contribution
This case report highlights the rare but severe association between Hashimoto’s thyroiditis and lymphocytic acute myocarditis with cardiogenic shock.
Findings
The patient showed improvement in hemodynamic stability and normalization of heart function after treatment.
Autoimmune features like Hashimoto’s thyroiditis are linked to worse outcomes in lymphocytic myocarditis.
Electrocardiogram findings improved over time, including resolution of AV block and partial RBBB improvement.
Abstract
Acute myocarditis (AM) is an inflammatory heart disease that may occur as a consequence of autoimmune disorders. Although the correlation between myocarditis and hyperthyroidism has been reported in the literature, the association with hypothyroidism is less frequent. We describe a characteristic case of lymphocytic acute myocarditis deteriorated into cardiogenic shock due to Hashimoto’s thyroiditis treated with vasopressor and inotropic drugs in combination with corticosteroid. On admission, electrocardiography revealed a sinus tachycardia with 1st degree atrioventricular (AV) block, right bundle branch block (RBBB), and left anterior fascicular block. Laboratory tests demonstrated a severe hypothyroidism and high-titre serum of antibodies against thyroglobulin. She presented a favourable clinical course, restoring haemodynamic stability. A resolution of hypothyroidism and a…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 1
Figure 2
Figure 3
Figure 4| Studies | Type | Thyroid function | Antibodies | Diagnosis | Presentation | CRM | Coronary angiography | Endomyocardial biopsy |
|---|---|---|---|---|---|---|---|---|
| Lorin De La Grandmaison G | CR | Hypothyroidism | Anti-thyroglobulin antibodies | Hashimoto’s thyroiditis | Sudden cardiac death | Not performed | Not performed | Lymphocytic infiltration (T CD3-CD5) with same macrophages) |
| Mavrogeni | CS | Early phase of hyperthyroidism, then normal thyroid function | Anti-microsomal and anti-thyroglobulin antibodies | Not available | Chest pain | Positive 15/50 patients. LGE was identified in infero-lateral wall of 8/15. | Normal coronaries | Lymphocytic myocarditis patter |
| Fatourechi and Edwards | CS | Hyperthyroidism | Not available | 59 patients Graves’ disease | Low-output heart failure | Not performed | Not performed | 11 biopsy available: 2 (18%) showed lymphocytic infiltrates |
| Chen | CR | Hyperthyroidism | Antithyroid peroxidase antibody | Graves’ disease with Hashimoto autoimmune component | Hyperpyrexia and sinus tachycardia evolved in low-output heart failure | Not performed | Not performed | Lymphocytic myocarditis with moderate T lymphocyte |
| Demoulin | CR | Hypothyroidism | Anti-thyroglobulin antibody | Hashimoto’s thyroiditis | Sudden cardiac death | Not performed | Not performed | Lymphocytic infiltration (T CD3 and T CD5 associated with B CD20 lymphocytes) and some macrophages |
| Yagoro | CR | Hypothyroidism | Anti-microsomal antibodies | Post-partum autoimmune | Syncope AV block | Not performed | Normal coronaries | Mild lymphocytic infiltration and disarrangement of myocytes |
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsViral Infections and Immunology Research · Eosinophilic Disorders and Syndromes · Pericarditis and Cardiac Tamponade
Introduction
Acute myocarditis (AM) is an inflammatory heart disease, diagnosed by established histological, immunological, and immunohistochemical criteria, that may occur as consequence of infections, exposure to toxic substances, drugs, and immune system activation.^1^ Based on the cell types infiltrating, myocarditis can be classified as eosinophilic, lymphocytic, giant cells, or granulomatous.
The presentation pattern can range from non-specific symptoms such as chest pain associated with fatigue and shortness of breath to more aggressive features characterized by left ventricular systolic dysfunction, ventricular arrhythmias (VA), or cardiogenic shock. Life-threatening VA may present at any stage of the disease as an expression of myocardial electrical instability. Brady-arrhythmias are infrequent except for some special aetiologies (cardiac sarcoidosis, giant cell myocarditis, Chagas disease, or some systemic autoimmune diseases). Acute myocarditis can be associated with autoimmune disorders or organ/system-specific autoimmune/inflammatory diseases.^1–3^
In this setting, although the correlation between myocarditis and hyperthyroidism is well documented in the literature,^4^ association with hypothyroidism remains less understood. We describe a characteristic case of AM associated with severe hypothyroidism due to Hashimoto’s disease.
Summary figure
Ab, antibodies; ANA, antinuclear antibodies; anti-TG, anti-thyroglobulin; CMR, cardiac magnetic resonance; EMB, endomyocardial biopsy; ECG, electrocardiogram; Echo, echocardiography; LAFB, left anterior fascicular block; LGE, late gadolinium enhancement; LPFB, left posterior fascicular block; LVEF, left ventricular ejection function; RBBB, right bundle branch block; TPO, antithyroid peroxidase.
**
Case presentation
A 49-year-old woman with no family history of cardiovascular disease and no cardiovascular risk factors was admitted to the Emergency Department of our hospital with persistence of high-grade fever (up to 39.0°C), dyspnoea and sub-sternal oppressive chest pain, which worsened during inspiration and improved by sitting up and leaning forward. Her medical history reported a previous diagnosis of hyperthyroidism three months before hospitalization but no medical treatment was started.
On admission, general examination was unremarkable. Blood pressure was 110/70 mmHg, and pulse rate was 110 beats per min. Her body temperature was 37.8°C. Electrocardiogram (ECG) revealed sinus tachycardia with 1st degree atrioventricular (AV) block, right bundle branch block (RBBB), and left anterior fascicular block (LAFB) (Figure 1A). Bedside transthoracic echocardiography (TTE) showed a normal left ventricular (LV) size with severely impaired cardiac function (LV ejection fraction ∼20%) and diffuse global hypokinesia. Right ventricular systolic function was mildly impaired with a tricuspid annular plane systolic excursion of 13 mm and circular pericardial effusion (see Supplementary material online, Video 1). Emergency coronary angiography documented non-obstructive coronary artery disease.
Electrocardiogram. (A) Initial ECG on arrival to emergency department showing sinus tachycardia with 1st degree atrioventricular (AV) block, complete right bundle branch block (RBBB), and left anterior fascicular block (LAFB). (B) The ECG performed on discharge showed resolution of 1st degree AV block and LAFB and the occurrence of left posterior fascicular block (LPFB) and partial improvement of RBBB.
The patient was admitted to the coronary care unit, in stable general conditions; no oxygenation disorder was observed. Laboratory tests showed high sensitivity cardiac Troponin T peak at 3202 pg/mL and a significant hypothyroidism (TSH 30 µIU/mL, FT3 3.26 pmol/L, FT4 11.3 pmol/L). Levothyroxine replacement therapy was started (25 µg). Results of viral assays (Herpes Virus, Epstein–Barr virus, Parvovirus, Cytomegalovirus, and Coxsackie) were negative, and the rheumatologic panel demonstrated the presence of antinuclear antibodies (ANA) and anti-DNA antibodies.
On Day 2, the patient developed pulmonary oedema with hypoxemic respiratory failure, requiring loop diuretics and mechanical ventilation; she quickly deteriorated into cardiogenic shock characterized by hypotension and clinical (cold sweated extremities, oliguria, mental confusion, dizziness) and biochemical (metabolic acidosis and elevated serum lactate) manifestations of hypoperfusion. An inotropic support was initiated. She developed a 3rd degree AV block. Despite supportive measures, her clinical status continued to deteriorate. Therefore, the patient was transferred to the cardiogenic shock referral care centre.
Inotropic support with epinephrine (0.05 mg/kg/min) and dobutamine (5 mg/kg/min) was started, and levosimendan (0.1 mg/kg/min) was administered with a significant progressive improvement in cardiac function. On Day 3, endomyocardial biopsy was performed: histology showed intense mononuclear inflammatory interstitial pattern with diffused cardiomyocyte damage. On immunohistochemistry, most inflammatory cells were CD3+ T lymphocytes and CD68+ macrophages (Figure 2). A diagnosis of severe, active, lymphocytic myocarditis was formulated. The search for viral genomes on sampled tissue and blood was negative. The patient received systemic loop diuretics and high-dose boluses of methylprednisolone (1 g/day during 72 h) under suspicion of AM virus negative. She presented a favourable clinical course, restoring haemodynamic stability. After the gradual weaning of inotropic support, on Day 4, extubation was planned. On Day 8, TTE revealed a normal LV size with mildly impaired cardiac function (LV ejection function 45%) and diffuse global hypokinesia.
Endomyocardial biopsy. (A) There is an intense and diffuse mononuclear interstitial inflammatory infiltrate in association with damage and necrosis of cardiac myocytes (haematoxylin and eosin; original magnification: 10×). (B) Immunohistochemistry for CD3 shows that a large portion of the inflammatory infiltrate is composed by CD3+ T lymphocytes, with formation of clusters (immunohistochemistry, original magnification: 10×).
The patient was transferred to the intermediate care unit (ICU) on Day 10. Laboratory tests demonstrated TSH 7,08 µIU/mL, FT3 2,59 pmol/L, FT4 14,9 pmol/L, antibodies against thyroid peroxidase 32 IU/mL (normal value < 60 IU/mL), and thyroglobulin 1803 IU/mL (normal value < 115 IU/mL). Electrocardiogram, performed on Day 10, reported an improvement in conduction abnormalities, marked by the resolution of 1st degree AV block and LAFB with the occurrence of the left posterior fascicular block and partial improvement of RBBB (Figure 1B) along with the normalization of LV systolic function (see Supplementary material online, Video 2). Electrocardiogram monitoring revealed non-sustained VA. Cardiac magnetic resonance with gadolinium contrast, including T1 and T2 mapping and T2-STIR sequences, was performed on Day 12 using a 1.5 T scanner (Figures 3 and 4) (see Supplementary material online, Video 3). Corticosteroid (prednisone 1 mg/kg daily) therapy was administered for 4 weeks, followed by 0.33 mg/kg for 5 months. Additionally, azathioprine 2 mg/day was initiated as a maintenance agent. During hospitalization in ICU, she remained asymptomatic and on Day 35, she was transferred to a rehabilitation centre.
Cardiac magnetic resonance images. (A) Short-axis view showing diffuse oedema in the left ventricular wall in T2 Short Time inversion recovery (STIR) sequences. (B and C) Three-chamber view (B) and short-axis view (B) demonstrate myocardial late gadolinium enhancement with sub-epicardial distribution in the mid-apical segment of antero-septal wall and in the basal segment of inferior and infero-lateral walls (arrows).
Cardiac magnetic resonance images. (A) Bullseye plot showing the native T1 times. Segmentation was performed according to the AHA 16-segment model. (B and C) Native T1 times and T1-enhanced were increased in all segments, especially in mid and apical segments. (D) Bullseye plot showing the native T2 times. (E) Native T2 times were increased in all segments, especially in mid and apical segments.
Discussion
We are reporting a characteristic case of AM associated with severe hypothyroidism due to Hashimoto’s disease. As known, AM can be linked to autoimmune disorders. Identifying the myocarditis-related condition is crucial for specific therapies. The presentation pattern can range from non-specific symptoms to a more aggressive features characterized by cardiogenic shock.^2^ In our experience, early allocation to a centre with expertise in cardiac assist devices was necessary in order to consider a prompt and specific treatment if conservative pharmacologic approaches had failed.^3^
Brady-arrhythmias, occurred in our patient, are infrequent, except for some special aetiologies or some systemic autoimmune diseases involving the myocardium. The pathophysiology of heart blocks has been attributed to a selective infiltration by CD3+ T mononuclear cells of the conduction system.^5,6^ The same electrocardiographic alterations, reported in our patient, were described in a 53-year-old man with AM, who died due to multiorgan failure. In our experience, the progressive resolution of inflammation and extensive injury resulted in LAFB disappearance, resolution of AV block, and an incomplete RBBB appearance.
Endomyocardial biopsy confirmed the diagnosis of lymphocytic myocarditis^1,3^ and influenced the treatments and prognosis, since it was the basis for safe (infection-negative) immunosuppression treatment.^7,8^ Cardiac magnetic resonance imaging provides non-invasive tissue characterization of the myocardium, according to Lake-Louise criteria.^9^
The immunological profile of our patient revealed a high-titre serum of antibodies against thyroglobulin, DNA, and ANA in a clinical setting compatible with Hashimoto’s thyroiditis. Hashimoto’s thyroiditis is the most frequent autoimmune thyroid disorder and the leading cause of hypothyroidism. In patients with autoimmune thyroid disorders, it is common to report a high prevalence of antibodies against DNA, since ∼20% of patients is suffering from other organ-specific/systemic autoimmune diseases. The association is rooted in both common genetic susceptibility and environmental factors.^10^ In these disorders, there is a common immune-pathogenic pathway, in which Th1-orientated immune response prevails. Lymphocytic infiltration, especially of T cells, and follicular destruction are the histological hallmarks of autoimmune thyroiditis, leading to gradual atrophy and fibrosis. However, few data are available on the association between thyroid disease and lymphocytic AM. Although the pathogenic mechanisms of the associations are not clear, we can assume that immune defects, immunological cross-reactivity, hormones, and genetic and environmental factors may play a central role in poly-autoimmunity.^10^ Autoimmune features, mostly Hashimoto’s thyroiditis, are associated in lymphocytic AM to a worse prognosis and an increased risk of recurrence, as reported after 20-year follow-up of the TIMIC trial.^7^
Table 1 * ^ 11–16 ^ summarizes published reports and case series of autoimmune thyroid disorders associated with lymphocytic myocarditis. Lorin De La Grandmaison et al.^11^ reported an autopsy case of lymphocytic myocarditis associated with Hashimoto’s thyroiditis: in both the heart and thyroid gland had a nodular pattern with germinal centre with prevalence of CD3+ and CD5+ T lymphocytes.
Finally, more studies are needed to elucidate the true prevalence of lymphocytic myocarditis related to autoimmune thyroiditis and clarify a possible common underlying autoimmune mechanism.
Supplementary Material
ytae268_Supplementary_Data
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636–48, 48a-48d.23824828 10.1093/eurheartj/eht 210 · doi ↗ · pubmed ↗
- 2Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document. Circ Heart Fail 2020;13:e 007405.33176455 10.1161/CIRCHEARTFAILURE.120.007405 PMC 7673642 · doi ↗ · pubmed ↗
- 3Ammirati E, Moslehi JJ. Diagnosis and treatment of acute myocarditis: a review. JAMA 2023;329:1098–1113.37014337 10.1001/jama.2023.3371 · doi ↗ · pubmed ↗
- 4Wu L, Wang W, Leng Q, Tang N, Zhou N, Wang Y, et al Focus on autoimmune myocarditis in Graves’ disease: a case-based review. Front Cardiovasc Med 2021;8:678645.34307494 10.3389/fcvm.2021.678645 PMC 8292634 · doi ↗ · pubmed ↗
- 5Peretto G, Sala S, Rizzo S, De Luca G, Campochiaro C, Sartorelli S, et al Arrhythmias in myocarditis: state of the art. Heart Rhythm 2019;16:793–801.30476544 10.1016/j.hrthm.2018.11.024 · doi ↗ · pubmed ↗
- 6Caro-Codón J, Muñoz SL, López-de-Sa E. Inflammatory infiltration of the cardiac conduction system in acute lymphocytic myocarditis. Eur Heart J 2022;43:4519.36130312 10.1093/eurheartj/ehac 507 · doi ↗ · pubmed ↗
- 7Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 2009;30:1995–2002.19556262 10.1093/eurheartj/ehp 249 · doi ↗ · pubmed ↗
- 8Chimenti C, Russo MA, Frustaci A. Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial. Eur Heart J 2022;43:3463–3473.35831932 10.1093/eurheartj/ehac 348PMC 9492235 · doi ↗ · pubmed ↗
